Homozygous Val6Gly Variation in <b><i>PRDM5</i></b> Gene Causing Brittle Cornea Syndrome: A New Turkish Case

Abstract

<b><i>Introduction:</i></b> Brittle cornea syndrome (BCS) is a rare connective tissue disorder with ocular and systemic features. Extreme corneal thinning and fragility are the main hallmarks of BCS. <b><i>Case Report:</i></b> A 4-year-old boy presented with recurrent spontaneous corneal perforation. He had blue sclera, corneal leucoma, irregular iris, shallow anterior chamber, corneal astigmatism, and bilateral corneal thinning. He also had several systemic features including hearing loss, skin hyperelasticity, joint hypermobility, scoliosis, and umbilical hernia. A diagnosis of BCS was confirmed with molecular analysis. A homozygous c.17T&#x3e;G, p.(Val6Gly) variation was identified in the <i>PRDM5</i> gene. <b><i>Discussion:</i></b> p.(Val6Gly) variation in <i>PRDM5</i> was previously reported in 2 patients with BCS. We also considered <i>PRDM5</i> c.17T&#x3e;G, p.(Val6Gly) variation as pathogenic based on the following features: the absence of the variation in population databases, in silico predictions, segregation analysis, and clinical signs of our patient. Extremely thin and brittle corneas lead to corneal perforation spontaneously or after minor trauma. Nearly all patients have lost their vision because of corneal rupture and scars. The key challenge in the management of BCS is the prevention of ocular rupture which relies on early diagnosis. Early diagnosis allows for taking prompt measures to prevent ocular rupture.